Borregaard ASA (BRGAY)
- Previous Close
0.00 - Open
35.15 - Bid 30.65 x --
- Ask 43.20 x --
- Day's Range
35.15 - 35.15 - 52 Week Range
28.00 - 38.09 - Volume
100 - Avg. Volume
0 - Market Cap (intraday)
1.753B - Beta (5Y Monthly) --
- PE Ratio (TTM)
24.24 - EPS (TTM)
1.45 - Earnings Date Jan 29, 2025
- Forward Dividend & Yield 0.68 (1.93%)
- Ex-Dividend Date Apr 12, 2024
- 1y Target Est
--
Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents; and advanced bioethanol products. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
www.borregaard.com1,127
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BRGAY
View MorePerformance Overview: BRGAY
Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BRGAY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BRGAY
View MoreValuation Measures
Market Cap
1.82B
Enterprise Value
2.01B
Trailing P/E
24.24
Forward P/E
20.53
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.71
Price/Book (mrq)
3.94
Enterprise Value/Revenue
2.86
Enterprise Value/EBITDA
11.57
Financial Highlights
Profitability and Income Statement
Profit Margin
10.87%
Return on Assets (ttm)
8.61%
Return on Equity (ttm)
16.43%
Revenue (ttm)
7.48B
Net Income Avi to Common (ttm)
813M
Diluted EPS (ttm)
1.45
Balance Sheet and Cash Flow
Total Cash (mrq)
172M
Total Debt/Equity (mrq)
43.74%
Levered Free Cash Flow (ttm)
293M
Company Insights: BRGAY
BRGAY does not have Company Insights